Infecção em Pacientes Neutropênicos: AvaIiação Retrospectiva de Fatores de Risco e da Eficácia Terapêutica
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n3.3264Keywords:
Infections, Neutropenia, Risk FactorsAbstract
In order to try to evaluate risk factors during infection episodes in neutropeunic patients, a retrospective study was performed in 209 medical records of patients, admitted to the Instituto Nacional de Câncer, during a period of 36 months, who had 317 febrile episodes. Several factors, such as degree of neutropenia, bacteremia, lung infiltrates and severe thrombocytopenia (<30.000/ mm3) did influence the clinical evolution of the infections process. An univariate analysis demonstrated a higher mortality rate for those patients. Patients severely neutropenic (less than 100/m3) had significant higher incidence of the studied risk factors. There was an important correlation between the severity of neutropenia and the presence of bacteremia, lung infiltrates and severe thrombocytopenia. Patients who developed bacteremia or thrombocytopenia had a higher incidence of lung infiltrates and, consequently, a higher mortality rate. There was no statistic difference in therapeutical effectiveness among drug combinations utilized. However, the use of amikacin seems to improve infection control when added to the therapy.
Downloads
References
Schimpff SC: Therapy of infections in pacients with granulocytopenia. Med Clin North Am 1977; 61 1101-1118. DOI: https://doi.org/10.1016/S0025-7125(16)31284-6
Gickles EA, Green NH, Wiernik PH: Clinical presentation of infection in granulocytopenic patients, Arch Int Med 1975; 135: 315-19. DOI: https://doi.org/10.1001/archinte.1975.00330050089015
EORTC - Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. J. lnfectious Dis 1978: 137 14-29. DOI: https://doi.org/10.1093/infdis/137.1.14
Love L, Shimpff. S, Wiernik PH: Improved Prognosis for Granulocytopenic patients with Gram-negative bacteriemia. Am J Med 1980; 68 643-48. DOI: https://doi.org/10.1016/0002-9343(80)90243-0
Ginger c: Diffuse pulmonary infiltrates in immunosupressed patients: prospective study of 80 cases. Am J Med 1979; 66: 115. DOI: https://doi.org/10.1016/0002-9343(79)90515-1
Fanta CH, Pennington JE: Fever and new lung infiltrates in the immunocompromised host. Ciin Chest Med 1981; 2: 19-39. DOI: https://doi.org/10.1016/S0272-5231(21)00098-8
Rubin RH: The cancer patients with fever and pulmonar infiitrates: Etiology and diagnostic approach. Current CJinical Topics in lnfectious Diseases 1980; 288-303.
Pizzo PA, Robichaud KJ, Wesley R, Commers iR; Fever in the pediatric and young adult patients with cancer. A prospective study of 1001 episodes. Medicine 1982: 61; 153-65. DOI: https://doi.org/10.1097/00005792-198205000-00003
Rubin RH, Voung LS: Fever and septicemia in clinical aproach to infections in the compromised host. 1981; 75- 122. DOI: https://doi.org/10.1007/978-1-4615-6642-7_4
Stover DE, Zamon MB, Hajdu Si, Lange M, Gold J, Armstrong D: Bronchoalveolar iavage in the diagnosis of diffuse pulmonary infiltrates in the imunocompromised host. Ann Int Medicine 1984; 101; 1-7. DOI: https://doi.org/10.7326/0003-4819-101-1-1
Weiner RS, Bartin M,Gaie RP et aH; interstitiai pneumonitis after Bone Marrow Transplantation assesment of risk factors. Ann Int Medicine; 1986; 104; 168-74. DOI: https://doi.org/10.7326/0003-4819-104-2-168
Thompson JS, Severson cD, Parmeiy Mi, Marmarstein BL, Simmonds A: Pulmonary ''hipersensitivity'' reations induced by transfusion of non HL-A leukoaggiutinin, N Engi J Med 1971; 284; 1120-25. DOI: https://doi.org/10.1056/NEJM197105202842003
Drew WL, Finley TN, Goide DN: Diagnostic lavage and occult pulmonary hemorrhage in thrombocytopenic immunocompromised patients. Am Rev Resp Dis, 1977; 116: 215-221.
Brigham KL: Mechanisms of lung injury in Clinics in Chest Medicine 1982, January pg 9-24. DOI: https://doi.org/10.1016/S0272-5231(21)00141-6
Ognibene FP et al: Adult Respiratory Distress Syndrome in patients with severe neutropenia. N Engi J Med 1986; 315: 547-51. DOI: https://doi.org/10.1056/NEJM198608283150904
Brigham K, Wooiverton W, Biake et al: Increased sheep lung vascular permeability caused by pseudomonas bacteremia. J.Clin Invest 1974; 54-792. DOI: https://doi.org/10.1172/JCI107819
de Jongh CA, Joshi JH, Newman KA et al: Antibiotic Sinergism and response in gram-negative bacteremia in granulocytopenic cancer patients. Am J Med 1986; 80: Suppl 1 80: 96-11.
Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H, and the European Organization for Research and Treatment of cancer. Antimicrobial therapy Project Group: Prospective randomized comparison of three antibiotic regimens for empiric therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother 1986; 29: 263-70. DOI: https://doi.org/10.1128/AAC.29.2.263
